TABLE 2.
Steroids | Co-substrate | Activity (μmol/min) | Relative Activity (%) |
4-pregnen-11β,17,21-triol-20,3-dione | NADH | 21 ± 1.4 | 100 |
4-pregnen-17,21-diol-3,20-dione | NADH | 10.5 ± 1.3 | 49.8 |
5β-pregnan-3α,11β,17,21-tetrol-20-one | NADH | 10.4 ± 1.7 | 49.2 |
4-pregnen-11β,21-diol-3,20-dione | NADH | 8.4 ± 1.3 | 39.8 |
4-pregnen-11β,17,20β,21-tetrol-3-one | NAD+ | 0.80 ± 0.02 | 4.1 |
4-pregnen-17,20β-diol-3-one | NAD+ | 0.43 ± 0.03 | 2.1 |
4-pregnen-11β,20β,21-triol-3-one | NAD+ | NA | NA |
4-pregnen-11β,17,20α,21-tetrol-3-one | NAD+ | NA | NA |
4-pregnen-17,20α-diol-3-one | NAD+ | NA | NA |
The reactions were initiated by addition of 50 nM purified enzyme to 0.5 ml of 0.05 M sodium phosphate buffer (pH 7) containing 0.15 M NaCl, 20% glycerol, 0.01 M 2-mercaptoethanol, 50 μM steroid, and 150 μM NAD(H) at 37°C. All values are the means of four replicates. NA, no activity.